Fig. 4From: LMP2-mRNA lipid nanoparticle sensitizes EBV-related tumors to anti-PD-1 therapy by reversing T cell exhaustionSafety of C2@mLMP2 combining αPD-1 in vivo. H&E staining of the heart, liver, spleen, lung, and kidney of mice from different groupsBack to article page